Publications by authors named "Nick Botwood"

Claim this Profile
P
Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III.
Jane D Robertson, Nick A Botwood, Mace L Rothenberg, Hans-Joachim Schmoll

Clin Colorectal Cancer· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non small-cell lung cancer.
Kenneth J O'Byrne, Sarah Danson, David Dunlop, Nick Botwood, Fumiko Taguchi

J Clin Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study.
Alex Chang, Purvish Parikh, Sumitra Thongprasert, Eng Huat Tan, Reury-Perng Perng, Nick Botwood

J Thorac Oncol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK.
Mike Aristides, Michael Lees, Nick Botwood, Jan McKendrick, Deborah A Stephenson

Eur J Health Econ· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis